Myriad Genetics provides the following resources in select languages:

Spanish

Descargar materiales educativos seleccionados del paciente en Espanyol

pdfForesight Carrier Screen Patient Brochure (Folleto para el paciente de detección de portador de Foresight)
pdfForesight Carrier Screen Fundamental Patient Brochure (Folleto para el paciente fundamental de detección de portador de Foresight)
pdfForesight Carrier Screen CF/SMA Only Patient Brochure (Folleto para el paciente solo de CF/SMA de detección de portador de Foresight)
pdfPrequel Prenatal Screen Patient Brochure (Folleto para el paciente de detección prenatal de Prequel)
pdfMyRisk Patient Brochure (Guía del paciente para el cáncer hereditario y las pruebas genéticas)

French

Télécharger des documents d'information du patient en français

pdfForesight Carrier Screen Patient Brochure (Brochure du patient sur le dépistage du statut de porteur Foresight)
pdfForesight Carrier Screen Fundamental Patient Brochure (Brochure du patient sur le dépistage du statut de porteur fondamental Foresight)
pdfForesight Carrier Screen CF/SMA Only Patient Brochure (Brochure du patient sur le dépistage du statut de porteur Foresight pour la mucoviscidose et l’amyotrophie spinale uniquement)
pdfPrequel Prenatal Screen Patient Brochure (Brochure du patient sur le dépistage prénatal Prequel)

Portuguese

Transferir os materiais educativos para o doente selecionados em português

pdfForesight Carrier Screen Patient Brochure (Folheto informativo para o doente do Foresight Carrier Screen)
pdfForesight Carrier Screen Fundamental Patient Brochure (Folheto informativo para o doente do Foresight Carrier Screen Fundamental)
pdfForesight Carrier Screen CF/SMA Only Patient Brochure (Folheto informativo para o doente do Foresight Carrier Screen CF/SMA Only)
pdfPrequel Prenatal Screen Patient Brochure (Folheto informativo para o doente do Prequel Prenatal Screen)

Chinese

下载特定患者教育宣传资料的简体中文版

pdfForesight Carrier Screen Patient Brochure (Foresight 携带者筛查患者手册)
pdfForesight Carrier Screen Fundamental Patient Brochure (Foresight 携带者基本筛查患者手册)
pdfForesight Carrier Screen CF/SMA Only Patient Brochure (Foresight CF/SMA 携带者筛查患者手册)
pdfPrequel Prenatal Screen Patient Brochure (Prequel 产前筛查患者手册)
pdfMyRisk Patient Brochure

Arabic

تنزيل المواد التعليمية المحددة للمريض باللغة [العربية]

pdfForesight Carrier Screen Patient Brochure (نشرة المريض الخاصة بفحص فحص Foresight لحاملي الأمراض الموروثة)
pdfForesight Carrier Screen Fundamental Patient Brochure (نشرة المريض الخاصة بأساسيات فحص فحص Foresight لحاملي الأمراض الموروثة)
pdfForesight Carrier Screen CF/SMA Only Patient Brochure (نشرة المريض الخاصة بفحص فحص Foresight لحاملي الأمراض الموروثة الخاص بالتليف الكيسي/الضمور العضلي نخاعي المنشأ)
pdfPrequel Prenatal Screen Patient Brochure (نشرة المريض الخاصة بفحص فحص Prequel السابق للولادة)

Foresight™ Carrier Screen enhanced with AGG analysis to refine reproductive risk for fragile X carriers

Research has shown that AGG interruption analysis can help us provide you and your patients who are found to be fragile X premutation carriers with a more refined reproductive risk. [1, 2] 

A higher number of AGG interruptions is associated with a lower risk of expansion. By counting the number of AGG repeats present, we can help refine the risk of a woman having a child affected with fragile X syndrome. [1, 2]

Counsyl is excited to announce that we are now offering AGG interruption analysis for select fragile X orders. [3]

graph_rev.png

Graph adapted from: www.fragilexcarrier.com

Applicable to ~1 in 200 women tested:* 

1. Patients identified with 55-90 CGG repeats for fragile X syndrome will automatically receive AGG interruption analysis via Asuragen. There will be no additional charge for this feature.

2. A preliminary Foresight™ Carrier Screen report will be issued within the normal two week turnaround time with Fragile X CGG repeat results and an final report will be issued within 3 weeks of the preliminary report with the results of the AGG interruption analysis.

3. AGG interruption analysis can not be performed on saliva samples. If a saliva sample returns with 55-90 CGG repeats, a secondary blood collection kit will be sent to your clinic in order to complete AGG analysis.

*Based on internal data

An updated informed consent form is necessary to cover this analysis. Log into counsyl.com/healthcare to access this updated form.

Note: AGG interruption analysis is not available for international orders

Questions? Contact communications@counsyl.com or reach out directly to your Counsyl representative.

Recent posts

SIGN UP FOR NEWS ALERTS

SIGN UP TODAY